THE MIDDLE EAST & AFRICA CONTRACEPTIVES MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

THE MIDDLE EAST & AFRICA CONTRACEPTIVES MARKET 2019-2027

Market By Age Group, Education, Drugs & Devices And End Users | Forecasts 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton Market Research’s report, the Middle East & African contraceptives market is expected to expand at a CAGR of 6.67% during the forecast years 2019-2027.

The countries covered in the Middle East & African region are:

O         Saudi Arabia

O         Turkey

O         The UAE

O         South Africa

O         rest of the Middle East & Africa

The major reasons for the growing popularity of contraceptives in the Middle East & African market are the irrational use of oral contraceptives by women, especially in Saudi Arabia. These oral pills are used to adjourn menstrual periods for a number of reasons. The economic development scenario in the MEA region is unbalanced.

However, South Africa shows considerable socio-economic development. The South African health minister, in 2014, announced that all public healthcare facilities would offer free contraceptives and make them widely accessible. The national governments in these regions need to increase investments made for birth control awareness programs and strengthen policies to increase the adoption of contraceptives. Introduction of contraception methods and raising awareness levels of the population will go a long way in propelling market growth. Barriers such as high costs and limited access to contraception techniques are the key restraints faced by the market.

The Middle East & African contraceptives market can be compartmentalized based on education, age groups, end users and drugs and devices. Oral pills and injectables are the majorly used forms of contraception used by Africans.

Technologically advanced contraceptives are highly effective and are also safe and reliable to use. Additionally, the improved incomes of the population help create demand for these products. In countries such as Turkey, the male populace is reluctant to make use of contraceptives due to the desire to reproduce until the birth of a son or many sons. This is a major challenge faced by the market in the MEA region.

The various companies engaged in the development of contraceptives are Okamoto Industries, Inc., SMB Corporation, Afaxys, Inc., Ocon Medical, Ltd., Mayer Laboratories, Inc., Church & Dwight Co., Inc., Agile Therapeutics, Reckitt Benckiser PLC, Pfizer, Inc., Melbea, Bayer AG, Allergan, Inc., Teva Pharmaceutical Industries, Ltd., Pregna, Apothecus Pharmaceutical Corporation, Cooper Surgical, Inc. and Merck & Co., Inc.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    CONTRACEPTIVE MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF COMPETITIVE RIVALRY

2.3. REGULATORY OUTLOOK

2.4. PESTEL OUTLOOK

2.5. MARKET ATTRACTIVENESS INDEX

2.6. MARKET PLAYER POSITIONING

2.7. KEY INSIGHTS

2.7.1.   ORAL CONTRACEPTIVE ARE THE MAJORLY USED CONTRACEPTIVE DRUGS

2.7.2.   CONDOMS ARE THE WIDELY USED CONTRACEPTIVES DEVICE

2.7.3.   AGE GROUP OF 15–24 YEARS ARE THE MAJOR REVENUE CONTRIBUTORS TO THE CONTRACEPTIVE MARKET

2.8. MARKET DRIVERS

2.8.1.   GROWING COGNIZANCE FOR CONTRACEPTIVES

2.8.2.   INCREASING USAGE OF ORAL CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY

2.8.3.   SURGE IN THE INITIATIVES OF GOVERNMENT AND NGO

2.8.4.   GROWING AWARENESS ABOUT STD

2.9. MARKET RESTRAINTS

2.9.1.   SIDE EFFECTS RESTRICTING THE GROWTH OF CONTRACEPTIVES

2.9.2.   LIMITED ACCESS TO CONTRACEPTIVES

2.10.            MARKET OPPORTUNITIES

2.10.1.                RISING DISPOSABLE INCOME IN EMERGING ECONOMIES

2.10.2.                UNMET MEDICAL NEEDS IN THE EMERGING ECONOMIES

2.10.3.                TECHNOLOGICAL ADVANCEMENTS

2.11.            MARKET CHALLENGES

2.11.1.                LACK OF ACCEPTANCE OF SOCIETY

3.    CONTRACEPTIVE MARKET OUTLOOK - BY EDUCATION

3.1. LESS THAN HIGH SCHOOL

3.2. HIGH SCHOOL GRADUATE

3.3. COLLEGE GRADUATE

3.4. OTHER COLLEGE DEGREES

4.    CONTRACEPTIVE MARKET OUTLOOK - BY AGE GROUP

4.1. 15–24 YEARS

4.2. 25–34 YEARS

4.3. 35–44 YEARS

4.4. ABOVE 44 YEARS

5.    CONTRACEPTIVE MARKET OUTLOOK - BY END USER

5.1. HOUSEHOLDS

5.2. CLINICS

5.3. HOSPITALS

6.    CONTRACEPTIVE MARKET OUTLOOK - BY DRUGS AND DEVICES

6.1. CONTRACEPTIVES DRUGS

6.1.1.   ORAL CONTRACEPTIVE PILLS

6.1.2.   INJECTABLE CONTRACEPTIVES

6.1.3.   TOPICAL CONTRACEPTIVES

6.2. CONTRACEPTIVE DEVICES

6.2.1.   MALE CONDOMS

6.2.2.   FEMALE CONDOMS

6.2.3.   DIAPHRAGMS

6.2.4.   CONTRACEPTIVE SPONGES

6.2.5.   VAGINAL RINGS

6.2.6.   SUBDERMAL IMPLANTS

6.2.7.   INTRA-UTERINE DEVICES

6.2.7.1.      COPPER INTRA-UTERINE DEVICES

6.2.7.2.      HORMONAL INTRA-UTERINE DEVICES

7.    CONTRACEPTIVE MARKET - REGIONAL OUTLOOK

7.1.1.   COUNTRY ANALYSIS

7.1.1.1.      UNITED ARAB EMIRATES

7.1.1.2.      TURKEY

7.1.1.3.      SAUDI ARABIA

7.1.1.4.      SOUTH AFRICA

7.1.1.5.      REST OF THE MIDDLE EAST & AFRICA

8.    COMPETITIVE LANDSCAPE

8.1. COMPANY PROFILES

8.1.1.   ALLERGAN INC.

8.1.2.   BAYER AG

8.1.3.   MELBEA

8.1.4.   PREGNA

8.1.5.   PFIZER, INC.

8.1.6.   CHURCH & DWIGHT CO., INC.

8.1.7.   AFAXYS, INC.

8.1.8.   APOTHECUS PHARMACEUTICAL CORPORATION

8.1.9.   COOPER SURGICAL INC

8.1.10.                OKAMOTO INDUSTRIES, INC

8.1.11.                MAYER LABORATORIES, INC.

8.1.12.                AGILE THERAPEUTICS

8.1.13.                MERCK & CO., INC.

8.1.14.                RECKITT BENCKISER PLC

8.1.15.                SMB CORPORATION

8.1.16.                TEVA PHARMACEUTICAL INDUSTRIES LTD.

8.1.17.                OCON MEDICAL LTD

9.    METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of table

TABLE 1        THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

TABLE 2        CONTRACEPTIVE   MARKET PLAYER POSITIONING OUTLOOK 2017

TABLE 3        THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 4        THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 5        THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 6        THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 7        THE MIDDLE EAST AND AFRICA CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        THE MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 9        THE MIDDLE EAST AND AFRICA INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 10      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 2      PORTER’S FIVE FORCE MODEL

FIGURE 3      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)

FIGURE 4      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)

FIGURE 5      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)

FIGURE 6      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)

FIGURE 7      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)

FIGURE 8      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)

FIGURE 9      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)

FIGURE 10   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)

FIGURE 11   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)

FIGURE 12   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)

FIGURE 13   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 14   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)

FIGURE 15   THE MIDDLE EAST AND AFRICA CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)

FIGURE 16   THE MIDDLE EAST AND AFRICA CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 17   THE MIDDLE EAST AND AFRICA CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 18   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)

FIGURE 19   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 20   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 21   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)

FIGURE 22   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)

FIGURE 23   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)

FIGURE 24   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)

FIGURE 25   THE MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 26   THE MIDDLE EAST AND AFRICA INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 27   THE MIDDLE EAST AND AFRICA INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 28   UNITED ARAB EMIRATES CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 29   TURKEY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 30   SAUDI ARABIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 31   SOUTH AFRICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 32   REST OF THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;